$VBIO
Valion Bio, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$1.21
▼-16.55%-$0.240
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateValion Bio, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Flagged at $3.04 at 07:46 AM on Sep 30, then ran to $4.39 +44% that session.
The high is the session peak after our first alert, not a realized trade. Not investment advice.
Why is VBIO down today? It is at $1.21 (-16.55%), and our scanner flagged it 72 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment VBIO spikes, and full due diligence on VBIO — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $VBIO 72 times in the last 30 days. Create a free account to track $VBIO, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
VBIO is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 16 unusual-volume and momentum alerts on VBIO today, peaking at 1873.2x its normal volume. Fresh from the SEC: Valion Bio, Inc.: Valion Bio's Next-Generation NMR Partnership with LarmorBio Delivers. A material company disclosure like this is often the real catalyst behind a move of this size.
Likely catalystValion Bio's Next-Generation NMR Partnership with LarmorBio Delivers, from an SEC filing. Read it →| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Wolf Lisa G Officer | Sold (automatic/other) | -2 | sold 6.9% | 27 | $4 at $2.12 | Sep 18, 26 |
Wolf Lisa G Officer | Other | 4 | added 16% | 29 | n/a | Sep 18, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
The tickers our scanner is lighting up most over the last 48 hours.
Comparable names in pharmaceutical preparations, closest in size first.
VBIO is one of today's most active names, trading on unusually heavy volume (live price and day move above). Our scanner has fired 16 unusual-volume and momentum alerts on VBIO today, peaking at 1873.2x its normal volume. Fresh from the SEC: Valion Bio, Inc.: Valion Bio's Next-Generation NMR Partnership with LarmorBio Delivers. A material company disclosure like this is often the real catalyst behind a move of this size.
VBIO last traded at $1.21, down 16.55% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Valion Bio, Inc. Common Stock (VBIO) is next expected to report earnings on Friday, November 13, 2026, about 29 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The VBIO Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged VBIO 72 times in the last 30 days.
VBIO (Valion Bio, Inc. Common Stock) trades on XNAS, with a market cap of about $1M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge VBIO for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$VBIO discussion
Sign in to ask a question or join the discussion.